HIF1A and neoplasm: In the hypoxic tumor TME, exosomes further exacerbate resistance and tumor progression by delivering HIF-1α and specific miRNAs that promote angiogenesis, metabolic adaptation, and therapeutic resilience, as demonstrated by Youssef et al. and colleagues [98,109,111,112,121].